Seyed Reza Jafarzadeh

Seyed Reza Jafarzadeh

Auto-generated profile, based on publicly available information

Seyed Reza Jafarzadeh

Boston University Chobanian and Avedisian School of Medicine Boston Massachusetts

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
JLJason Lombard
Jason Lombard
IGI.A. Gardner
I.A. Gardner
SJS.R. Jafarzadeh
S.R. Jafarzadeh
CFC.P. Fossler
C.P. Fossler
BHB. Harris
B. Harris
WJW.O. Johnson
W.O. Johnson

1 August 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
KBKathryn Bacon
Kathryn Bacon
MLMichael P LaValley
Michael P LaValley
SJS Reza Jafarzadeh
S Reza Jafarzadeh
DFDavid Felson
David Felson
Objectives Although treatment development in osteoarthritis (OA) focuses on chondroprotection, it is unclear how much preventing cartilage loss reduces joint pain. It is also unclear how nociceptive tissues may be involved. Methods Using data from the Osteoarthritis Initiative, we quantified the relation between cartilage loss and worsening knee pain after adjusting for bone marrow lesions (BMLs) and synovitis, and examined how much these factors mediated this association. 600 knee MRIs were scored at baseline, 12 months and 24 months for quantitative and semiquantitative measures of OA structural features. We focused on change in medial cartilage thickness using an amount similar to that seen in recent trials. Linear models calculated mean change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score with cartilage loss, adjusted for baseline BMLs, synovitis and covariates. Mediation analysis tested whether change in synovitis or BMLs mediated the cartilage loss–pain association. We carried out a subanalysis for knees with non-zero baseline WOMAC pain scores and another for non-valgus knees. Results Cartilage thickness loss was significantly associated with a small degree of worsening in pain over 24 months. For example, a loss of 0.1 mm of cartilage thickness over 2 years was associated with a 0.32 increase in WOMAC pain (scale 0–20). The association of cartilage thickness loss with pain was mediated by synovitis change but not by BML change. Subanalysis results were similar. Conclusions Cartilage thickness loss is associated with only a small amount of worsening knee pain, an association mediated in part by worsening synovitis. Demonstrating that chondroprotection reduces knee pain will be extremely challenging and is perhaps unachievable.

27 November 2017 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
SJS. Reza Jafarzadeh
S. Reza Jafarzadeh
DFDavid T. Felson
David T. Felson
Objective: National estimates of arthritis prevalence rely on a single survey question about doctor‐diagnosed arthritis without using survey information on joint symptoms, even though some subjects with only the latter have been shown to have arthritis. The sensitivity of the current surveillance definition is only 53% and 69% in subjects ages 45–64 years and ages ≥65 years, respectively, resulting in misclassification of nearly one‐half and one‐third of subjects in those age groups. This study was undertaken to estimate arthritis prevalence based on an expansive surveillance definition that is adjusted for the measurement errors in the current definition.Methods: Using the 2015 National Health Interview Survey, we developed a Bayesian multinomial latent class model for arthritis surveillance based on doctor‐diagnosed arthritis, joint symptoms, and whether symptom duration exceeded 3 months.Results: Of 33,672 participants, 19.3% of men and 16.7% of women ages 18–64 years and 15.7% of men and 13.5% of women ages ≥65 years affirmed joint symptoms without doctor‐diagnosed arthritis. The measurement error–adjusted prevalence of arthritis was 29.9% (95% Bayesian probability interval [95% PI] 23.4–42.3) in men ages 18–64 years, 31.2% (95% PI 25.8–44.1) in women ages 18–64 years, 55.8% (95% PI 49.9–70.4) in men ages ≥65 years, and 68.7% (95% PI 62.1–79.9) in women ages ≥65 years. Arthritis affected 91.2 million adults (of 247.7 million; 36.8%) in the US in 2015, which included 61.1 million persons between 18 and 64 years of age (of 199.9 million; 30.6%). Our arthritis prevalence estimate was 68% higher than the previously reported national estimate.Conclusion: Arthritis prevalence in the US population has been substantially underestimated, especially among adults younger than 65 years of age.

19 September 2017 in The Journal of the American Dental Association
Verified
Journal Article
Open access
PDF file
MDMichael J. Durkin
Michael J. Durkin
KHKevin Hsueh
Kevin Hsueh
YSYa Haddy Sallah
Ya Haddy Sallah
QFQianxi Feng
Qianxi Feng
SJS. Reza Jafarzadeh
S. Reza Jafarzadeh
VFVictoria J. Fraser
Victoria J. Fraser
Background Antibiotic prescribing practices among general dentists and dental specialists in the United States remains poorly understood. The purpose of this study was to compare prescribing practices across dental specialties, evaluate the duration of antibiotics dentists prescribed, and determine variation in antibiotic selection among dentists. Methods The authors performed a retrospective cross-sectional analysis of dental care provider specialties linked to deidentified antibiotic claims data from a large pharmacy benefits manager during the 2015 calendar year. Results As a group, general dentists and dental specialists were responsible for more than 2.9 million antibiotic prescriptions, higher than levels for several other medical and allied health care provider specialties. Antibiotic treatment duration generally was prolonged and commonly included broad-spectrum agents, such as amoxicillin clavulanate and clindamycin. Although amoxicillin was the most commonly prescribed antibiotic among all dental specialties, there was substantial variation among other antibiotics each specialty selected. The most common antibiotic treatment durations were 7 and 10 days. Conclusions This study's results demonstrate that dentists frequently prescribe antibiotics for prolonged periods and often use broad-spectrum antibiotics. Further studies are necessary to evaluate the appropriateness of these antibiotic prescribing patterns. Practical Implications The clinically significant variation in antibiotic selection and treatment duration identified among all dental specialties in this study population implies that further research and guidance into the treatment of dental infections is necessary to improve and standardize antibiotic prescribing practices.

23 March 2022 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
MGMarthe Gløersen
Marthe Gløersen
PPPernille Steen Pettersen
Pernille Steen Pettersen
TNTuhina Neogi
Tuhina Neogi
SJS. Reza Jafarzadeh
S. Reza Jafarzadeh
MVMaria Vistnes
Maria Vistnes
IHIda K. Haugen
Ida K. Haugen
Objective: To examine the association of body mass index (BMI) with pain in people with hand osteoarthritis (OA), and explore whether this association, if causal, is mediated by systemic inflammatory biomarkers.Methods: In 281 Nor‐Hand study participants, we estimated associations between BMI and hand pain, as measured by the Australian/Canadian Osteoarthritis Hand Index (AUSCAN; range 0–20) and Numerical Rating Scale (NRS; range 0–10); foot pain, as measured by NRS (range 0–10); knee/hip pain, as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC; range 0–20); painful total body joint count; and pain sensitization. We fit natural‐effects models to estimate natural direct and natural indirect effects of BMI on pain through inflammatory biomarkers.Results: Each 5‐unit increase in BMI was associated with more severe hand pain (on average increased AUSCAN by 0.64 [95% confidence interval (95% CI) 0.23, 1.08]), foot pain (on average increased NRS by 0.65 [95% CI 0.36, 0.92]), knee/hip pain (on average increased WOMAC by 1.31 [95% CI 0.87, 1.73]), generalized pain, and pain sensitization. Mediation analyses suggested that the effects of BMI on hand pain and painful total body joint count were partially mediated by leptin and high‐sensitivity C‐reactive protein (hsCRP), respectively. Effect sizes for mediation by leptin were larger for the hands than for the lower extremities, and were statistically significant for the hands only.Conclusion: In people with hand OA, higher BMI is associated with greater pain severity in the hands, feet, and knees/hips. Systemic effects of obesity, measured by leptin, may play a larger mediating role for pain in the hands than in the lower extremities. Low‐grade inflammation, measured by hsCRP, may contribute to generalized pain in overweight/obese individuals.

1 October 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
AGAndrea S. Gershon
Andrea S. Gershon
SJS. Reza Jafarzadeh
S. Reza Jafarzadeh
KWKevin C. Wilson
Kevin C. Wilson
AWAllan J. Walkey
Allan J. Walkey
Well-done randomized trials provide accurate estimates of treatment effect by producing groups that are similar on all measures except for the intervention of interest. However, inferences of efficacy in tightly-controlled experimental settings may not translate into similar effectiveness in real-world settings. Observational studies generally enable inferences over a wider range of patient characteristics and evaluation of a broader range of outcomes over a longer period than randomized trials. However, clinicians are often reluctant to incorporate the findings of observational studies into clinical practice. Reason for uncertainty regarding observational studies include a lack of familiarity with observational research methods, occasional disagreements between results of observational studies and randomized trials, the perceived risk of spurious results from systematic bias, and prior teaching that randomized trials are the most reliable source of medical evidence. We propose that a better understanding of observational research will enhance clinicians’ ability to distinguish reliable observational studies from those that are subjected to biases and, therefore, provide more confidence to apply observational research results into clinical practice when appropriate. Herein, we explain why observational studies may be perceived as less conclusive than randomized trials, address situations in which observational research and randomized trials produced different findings, and provide information on observational study design so that quality can be evaluated. We conclude that observational research is a valuable source of medical evidence and that clinical action is strongest when supported by both high quality observational studies and randomized trials.